A potential treatment for covid-19 is a step closer to reality with a promising study involving hamsters showing a 97% reduction of coronavirus in lungs within 48 hours of treatment. Dr Jacob Glanville head of US company Distributed Bio has been working on the development of an anti-body treatment with the aim to begin trials with humans around September. He spoke to me about how his technology works, and what the success of the hamster trial means.